|
🐜
|
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
13 auth.
G. Ruiz‐Irastorza,
M. Cuadrado,
I. Ruiz-Arruza,
R. Brey,
M. Crowther,
R. Derksen,
D. Erkan,
S. Krilis,
S. Machin,
V. Pengo,
...
S. Pierangeli,
M. Tektonidou,
M. Khamashta
|
8 |
2011 |
8
🐜
|
|
🐬
|
Predictors of major infections in systemic lupus erythematosus
G. Ruiz‐Irastorza,
N. Olivares,
I. Ruiz-Arruza,
A. Martínez-Berriotxoa,
M. Egurbide,
C. Aguirre
|
8 |
2009 |
8
🐬
|
|
🦁
|
Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
I. Ruiz-Arruza,
A. Ugarte,
I. Cabezas‐Rodríguez,
J. Medina,
M. Morán,
G. Ruiz‐Irastorza
|
7 |
2014 |
7
🦁
|
|
🦁
|
Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long‐Term Disease Control: An Observational Study
7 auth.
I. Ruiz-Arruza,
J. Lozano,
I. Cabezas‐Rodríguez,
J. Medina,
A. Ugarte,
J. Erdozain,
...
G. Ruiz‐Irastorza
|
6 |
2018 |
6
🦁
|
|
🦁
|
Comparison of high versus low-medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis.
I. Ruiz-Arruza,
Cristiana Barbosa,
A. Ugarte,
G. Ruiz‐Irastorza
|
6 |
2015 |
6
🦁
|
|
🐜
|
Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study
25 auth.
O. Amengual,
R. Forastiero,
M. Sugiura-Ogasawara,
K. Otomo,
K. Oku,
C. Favas,
J. Alves,
P. Žigon,
A. Ambrožič,
M. Tomšič,
I. Ruiz-Arruza,
G. Ruiz‐Irastorza,
M. Bertolaccini,
G. Norman,
Z. Shums,
...
J. Arai,
A. Murashima,
A. Tebo,
M. Gerosa,
P. Meroni,
I. Rodríguez-Pintó,
R. Cervera,
J. Swadźba,
J. Musial,
T. Atsumi
|
5 |
2017 |
5
🐜
|
|
🐜
|
Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis
7 auth.
A. Haddad,
A. Thavaneswaran,
I. Ruiz-Arruza,
F. Pellett,
V. Chandran,
R. Cook,
...
D. Gladman
|
5 |
2015 |
5
🐜
|
|
🐜
|
Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts.
9 auth.
G. Ruiz‐Irastorza,
B. Ruiz-Estevez,
E. Lazaro,
I. Ruiz-Arruza,
P. Duffau,
M. Martín-Cascón,
...
C. Richez,
A. Ugarte,
P. Blanco
|
5 |
2019 |
5
🐜
|
|
🐬
|
Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus
G. Ruiz‐Irastorza,
A. Ugarte,
I. Ruiz-Arruza,
M. Khamashta
|
4 |
2020 |
4
🐬
|
|
🐜
|
SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS
9 auth.
A. Fonollosa,
V. Llorenç,
J. Artaraz,
B. Jiménez,
I. Ruiz-Arruza,
Koldo Agirrebengoa,
...
M. Cordero‐Coma,
Felipe Costales‐Mier,
A. Adán
|
4 |
2016 |
4
🐜
|
